Hinge Health (HNGE)
Combines motion tracking, wearable therapy, and clinicians for employer-sponsored musculoskeletal care.
$93.42
vs last close−1.03 (−1.10%)
In millions of USD, except per-share figures
| In millions | Q3 FY23Sep 2023 | Q4 FY23Dec 2023 | Q1 FY24Mar 2024 | Q2 FY24Jun 2024 | Q3 FY24Sep 2024 | Q4 FY24Dec 2024 | Q1 FY25Mar 2025 | Q2 FY25Jun 2025 | Q3 FY25Sep 2025 | Q4 FY25Dec 2025 | Q1 FY26Mar 2026 | Q2 FY26Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 81 | 82 | 83 | 90 | 101 | 117 | 124 | 139 | 154 | 171 | 182 | 213 |
| Cost of revenue | 23 | 23 | 25 | 23 | 21 | 21 | 24 | 41 | 28 | 27 | 28 | 29 |
| Gross profit | 58 | 58 | 58 | 67 | 79 | 96 | 100 | 98 | 126 | 144 | 154 | 184 |
| 80 | 89 | 89 | 84 | 83 | 75 | 87 | 678 | 132 | 117 | 122 | 144 | |
| Research & development | 28 | 29 | 31 | 25 | 24 | 22 | 24 | 280 | 32 | 33 | 30 | 34 |
| 52 | 60 | 60 | 59 | 59 | 52 | 64 | 398 | 100 | 83 | 92 | 109 | |
| Selling & marketing | 52 | 60 | 42 | 45 | 45 | 35 | 47 | 147 | 64 | 59 | 69 | 81 |
| General & administrative | 0 | 0 | 17 | 14 | 15 | 17 | 17 | 251 | 37 | 24 | 23 | 28 |
| Other expenses | 0 | 0 | −1 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 |
| Operating income | −22 | −30 | −31 | −18 | −4 | 21 | 13 | −581 | −6 | 27 | 32 | 40 |
| 6 | 6 | 5 | 5 | 5 | 5 | 109 | 5 | 4 | 5 | 4 | 4 | |
| Other non-operating income | −6 | −6 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | −1 | 0 | −4 |
| Income before tax | −17 | −25 | −26 | −13 | 1 | 26 | 122 | −576 | −2 | 32 | 36 | 44 |
| Income tax expense | 0 | 0 | 0 | 0 | 1 | −1 | 1 | 0 | 0 | 0 | 1 | 1 |
| Net income from continuing operations | −17 | −24 | −26 | −13 | 0 | 27 | 121 | −576 | −2 | 32 | 35 | 44 |
| Net income | −17 | −24 | −26 | −13 | 0 | 27 | 121 | −576 | −2 | 32 | 35 | 44 |
| EPS, basic | −$0.21 | −$0.31 | −$0.34 | −$0.19 | $0.00 | $0.35 | $1.55 | −$7.38 | −$0.02 | $0.39 | $0.43 | $0.55 |
| EPS, diluted | −$0.21 | −$0.31 | −$0.34 | −$0.14 | $0.00 | $0.35 | $1.55 | −$7.38 | −$0.02 | $0.37 | $0.41 | $0.53 |
| Weighted average shares, basic | 78 | 78 | 78 | 69 | 78 | 78 | 78 | 78 | 79 | 80 | 79 | 79 |
| Weighted average shares, diluted | 78 | 78 | 78 | 92 | 78 | 78 | 78 | 78 | 79 | 85 | 82 | 82 |
| EBITDA | −17 | −24 | −31 | −17 | −3 | 23 | 14 | −579 | −6 | 30 | 33 | 45 |
| Depreciation & amortization | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| EBIT | −17 | −25 | −31 | −18 | −4 | 21 | 13 | −581 | −6 | 28 | 32 | 44 |
